An increasing number of reports have described the COVID-19–associated pulmonary aspergillosis (CAPA) as being a further contributing factor to mortality. Based on a recent consensus statement supported by international medical mycology societies, it has been proposed to define CAPA as possible, probable, or proven on the basis of sample validity and thus diagnostic certainty. Considering current challenges associated with proven diagnoses, there is pressing need to study the epidemiology of proven CAPA.

中文翻译：

---

经证实的 COVID-19 与严重呼吸衰竭患者相关的肺曲霉病

越来越多的报告将 COVID-19 相关的肺曲霉病 (CAPA) 描述为导致死亡率的进一步因素。基于最近得到国际医学真菌学学会支持的共识声明，建议根据样本有效性和诊断确定性将 CAPA 定义为可能的、可能的或已证实的。考虑到当前与已证实的诊断相关的挑战，迫切需要研究已证实的 CAPA 的流行病学。